Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Ahmed Abdelhak(University of California, San Francisco), Hayrettin Tumani(Universität Ulm), Albert C. Ludolph(Universität Ulm), Ari Green(University of California, San Francisco), Jens Kühle(University of Basel), Patrick Oeckl(Universität Ulm), Axel Petzold(Amsterdam UMC Location VUmc), Matteo Foschi(Ospedale "Santa Maria delle Croci" di Ravenna), Markus Otto(Universität Ulm), André Huss(University Hospital Ulm), John K. Yue(San Francisco General Hospital), Samir Abu‐Rumeileh(University Hospital Ulm), Geoffrey T. Manley(University of Antwerp), Lucio D’Anna(Charing Cross Hospital)
Cited by 809
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
|Nature Neuroscience|2015|782
A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)
|Intensive Care Medicine|2019|623
Symptomatology and Functional Outcome in Mild Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study
|Journal of Neurotrauma|2013|517